Last reviewed · How we verify

Clotrimazole troches

Hadassah Medical Organization · Phase 2 active Small molecule

Clotrimazole troches work by inhibiting fungal ergosterol synthesis, disrupting the fungal cell membrane and causing cell death.

Clotrimazole troches work by inhibiting fungal ergosterol synthesis, disrupting the fungal cell membrane and causing cell death. Used for Oral candidiasis (oropharyngeal thrush), Oral fungal infections.

At a glance

Generic nameClotrimazole troches
Also known asOralten
SponsorHadassah Medical Organization
Drug classAzole antifungal
TargetLanosterol 14α-demethylase (CYP51)
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhasePhase 2

Mechanism of action

Clotrimazole is an azole antifungal that inhibits the cytochrome P450-dependent enzyme lanosterol 14α-demethylase, which is essential for ergosterol synthesis in fungal cell membranes. By depleting ergosterol and allowing toxic sterol precursors to accumulate, the drug compromises membrane integrity and fungal cell viability. The troche formulation delivers the drug topically to oral and pharyngeal tissues for local antifungal effect.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results